NSEReply to Clarification- Financial results25 Jun 2026 · 25 Jun 2026, 05:55 pm

Reply to Clarification- Financial results

Gujarat Themis Biosyn Limited · GUJTHEM

✦ AI SummaryResults

Gujarat Themis Biosyn Limited clarifies the omission of Earnings Per Share (EPS) in their XBRL filing for the quarter ended 31-Mar-2026, stating it was an inadvertent technical error with no impact on financial performance or profitability.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

The Exchange had sought clarification from Gujarat Themis Biosyn Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.

Attachments (1)

📄

GUJARATTHEMIS_20062026155639_Clarification_to_NSE_EPS_query.pdf

pdf

Download →
View document text
GUJARAT THEMIS BIOSYN LIMITED CIN: L24230GJ1981PLC004878 REGD. OFFICE & FACTORY: 69/C GIDC INDUSTRIAL ESTATE, VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA TE: 0260-2430027 / 2400639 E-mail:hrm@gtbl.in.net 20th June, 2026 The Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400051 Symbol: GUJTHEM Dear Sir / Madam, Sub: Subject: Clarification regarding discrepancy in XBRL filing of Financial Results – EPS not mentioned With reference to your communication regarding the Financial Results XBRL submitted on May 25, 2026, wherein it has been observed that Earnings Per Share (EPS) was not mentioned in the XBRL filing, we wish to submit the following clarification: Due to an inadvertent omission while filing the financial results in XBRL format, the EPS disclosure was not captured in the XBRL submission. However, there is no change in the financial results approved by the Board of Directors and submitted to the Exchange. The omission is purely technical in nature and does not impact the financial performance, profitability, or any other financial information disclosed by the Company. We have taken note of the observation and are submitting the revised/corrected XBRL filing incorporating the EPS details as required. We request you to kindly take the above clarification on record and oblige. Thanking you. Yours faithfully, Kindly take the above on record. For GUJARAT THEMIS BIOSYN LIMITED Vineet Gawankar Company Secretary & Compliance Officer MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104 Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019 E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in